Literature DB >> 23792022

The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.

Eiichi Jodo1.   

Abstract

Phencyclidine (PCP) is a psychotomimetic drug that induces schizophrenia-like symptoms in healthy individuals and exacerbates pre-existing symptoms in patients with schizophrenia. PCP also induces behavioral and cognitive abnormalities in non-human animals, and PCP-treated animals are considered a reliable pharmacological model of schizophrenia. However, the exact neural mechanisms by which PCP modulates behavior are not known. During the last decade several studies have indicated that disturbed activity of the prefrontal cortex (PFC) may be closely related to PCP-induced psychosis. Systemic administration of PCP produces long-lasting activation of medial PFC (mPFC) neurons in rats, almost in parallel with augmentation of locomotor activity and behavioral stereotypies. Later studies have showed that such PCP-induced behavioral abnormalities are ameliorated by prior administration of drugs that normalize or inhibit excess excitability of PFC neurons. Similar activation of mPFC neurons is not induced by systemic injection of a typical psychostimulant such as methamphetamine, even though behavioral hyperactivity is induced to almost the same level. This suggests that the neural circuits mediating PCP-induced psychosis are different to those mediating methamphetamine-induced psychosis. Locally applied PCP does not induce excitation of mPFC neurons, indicating that PCP-induced tonic excitation of mPFC neurons is mediated by inputs from regions outside the mPFC. This hypothesis is strongly supported by experimental results showing that local perfusion of PCP in the ventral hippocampus, which has dense fiber projections to the mPFC, induces tonic activation of mPFC neurons with accompanying augmentation of behavioral abnormalities. In this review we summarize current knowledge on the neural mechanisms underlying PCP-induced psychosis and highlight a possible involvement of the PFC and the hippocampus in PCP-induced psychosis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMPA; Animal models; Electrophysiology; GABA; Hippocampus; MD; MK801; N-methyl-D-aspartate; NMDA; PCP; PFC; Phencyclidine; Prefrontal cortex; Schizophrenia; mPFC; medial prefrontal cortex; mediodorsal nucleus of the thalamus; phencyclidine; prefrontal cortex; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; γ-aminobutylic acid

Mesh:

Substances:

Year:  2013        PMID: 23792022     DOI: 10.1016/j.jphysparis.2013.06.002

Source DB:  PubMed          Journal:  J Physiol Paris        ISSN: 0928-4257


  22 in total

Review 1.  Prefrontal dysfunction and a monkey model of schizophrenia.

Authors:  Ping Mao; Ding Cui; Xu-Dong Zhao; Yuan-Ye Ma
Journal:  Neurosci Bull       Date:  2015-03-31       Impact factor: 5.203

2.  The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophrenia.

Authors:  Ayan Ghoshal; P Jeffrey Conn
Journal:  Future Neurol       Date:  2015

Review 3.  Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.

Authors:  Daniel J Foster; P Jeffrey Conn
Journal:  Neuron       Date:  2017-05-03       Impact factor: 17.173

4.  Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model.

Authors:  A Ghoshal; J M Rook; J W Dickerson; G N Roop; R D Morrison; N Jalan-Sakrikar; A Lamsal; M J Noetzel; M S Poslusney; M R Wood; B J Melancon; S R Stauffer; Z Xiang; J S Daniels; C M Niswender; C K Jones; C W Lindsley; P J Conn
Journal:  Neuropsychopharmacology       Date:  2015-06-25       Impact factor: 7.853

5.  Effects of D- and L-govadine on the disruption of touchscreen object-location paired associates learning in rats by acute MK-801 treatment.

Authors:  Brittney R Lins; Anthony G Phillips; John G Howland
Journal:  Psychopharmacology (Berl)       Date:  2015-09-11       Impact factor: 4.530

6.  Developmental Inhibition of Gsk3 Rescues Behavioral and Neurophysiological Deficits in a Mouse Model of Schizophrenia Predisposition.

Authors:  Makoto Tamura; Jun Mukai; Joshua A Gordon; Joseph A Gogos
Journal:  Neuron       Date:  2016-02-18       Impact factor: 17.173

7.  Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats.

Authors:  Susan B Powell; Asma Khan; Jared W Young; Christine N Scott; Mahalah R Buell; Sorana Caldwell; Elisa Tsan; Loek A W de Jong; Dean T Acheson; Jacinta Lucero; Mark A Geyer; M Margarita Behrens
Journal:  Dev Neurosci       Date:  2015-05-23       Impact factor: 2.984

8.  Phencyclidine Discoordinates Hippocampal Network Activity But Not Place Fields.

Authors:  Hsin-Yi Kao; Dino Dvořák; EunHye Park; Jana Kenney; Eduard Kelemen; André A Fenton
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

9.  Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256.

Authors:  Michael D Grannan; Catharine A Mielnik; Sean P Moran; Robert W Gould; Jacob Ball; Zhuoyan Lu; Michael Bubser; Amy J Ramsey; Masahito Abe; Hyekyung P Cho; Kellie D Nance; Anna L Blobaum; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  ACS Chem Neurosci       Date:  2016-10-05       Impact factor: 4.418

10.  Multiple long-range inputs evoke NMDA currents in prefrontal cortex fast-spiking interneurons.

Authors:  Luke Joseph Bogart; Patricio O'Donnell
Journal:  Neuropsychopharmacology       Date:  2018-02-26       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.